Application of Exosome-derived Noncoding RNAs in Bone Regeneration: Opportunities and Challenges

Overview

Journal World J Stem Cells

Publisher Baishideng Publishing Group

Date 2022 Sep 26

PMID 36157529

Authors

Yuan-Zhong Ren

Shan-Shan Ding

Ya-Ping Jiang

Hui Wen

Tao Li

Affiliations

Soon will be listed here.

Abstract

With advances in the fields of regenerative medicine, cell-free therapy has received increased attention. Exosomes have a variety of endogenous properties that provide stability for molecular transport across biological barriers to cells, as a form of cell-to-cell communication that regulates function and phenotype. In addition, exosomes are an important component of paracrine signaling in stem-cell-based therapy and can be used as a stand-alone therapy or as a drug delivery system. The remarkable potential of exosomes has paved the pathway for cell-free treatment in bone regeneration. Exosomes are enriched in distinct noncoding RNAs (ncRNAs), including microRNAs, long ncRNAs and circular RNAs. Different ncRNAs have multiple functions. Altered expression of ncRNA in exosomes is associated with the regenerative potential and development of various diseases, such as femoral head osteonecrosis, myocardial infarction, and cancer. Although there is increasing evidence that exosome-derived ncRNAs (exo-ncRNAs) have the potential for bone regeneration, the detailed mechanisms are not fully understood. Here, we review the biogenesis of exo-ncRNA and the effects of ncRNAs on angiogenesis and osteoblast- and osteoclast-related pathways in different diseases. However, there are still many unsolved problems and challenges in the clinical application of ncRNA; for instance, production, storage, targeted delivery and therapeutic potency assessment. Advancements in exo-ncRNA methods and design will promote the development of therapeutics, revolutionizing the present landscape.

Citing Articles

Adipose-derived stem cell exosomal miR-21-5p enhances angiogenesis in endothelial progenitor cells to promote bone repair via the NOTCH1/DLL4/VEGFA signaling pathway.

Cao L, Sun K, Zeng R, Yang H J Transl Med. 2024; 22(1):1009.

PMID: 39516839 PMC: 11549876. DOI: 10.1186/s12967-024-05806-3.

Exosomal miR-1a-3p derived from glucocorticoid-stimulated M1 macrophages promotes the adipogenic differentiation of BMSCs in glucocorticoid-associated osteonecrosis of the femoral head by targeting Cebpz.

Duan P, Yu Y, Cheng Y, Nie M, Yang Q, Xia L J Nanobiotechnology. 2024; 22(1):648.

PMID: 39438865 PMC: 11494760. DOI: 10.1186/s12951-024-02923-5.

Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing.

Shi H, Yang Y, Xing H, Jia J, Xiong W, Guo S J Tissue Eng. 2024; 15:20417314241286606.

PMID: 39371940 PMC: 11456177. DOI: 10.1177/20417314241286606.

Mechanically strained osteocyte-derived exosomes contained miR-3110-5p and miR-3058-3p and promoted osteoblastic differentiation.

Zhu Y, Li Y, Cao Z, Xue J, Wang X, Hu T Biomed Eng Online. 2024; 23(1):44.

PMID: 38705993 PMC: 11070085. DOI: 10.1186/s12938-024-01237-9.

Regulatory mechanisms of circular RNAs during human mesenchymal stem cell osteogenic differentiation.

Mazziotta C, Badiale G, Cervellera C, Tognon M, Martini F, Rotondo J Theranostics. 2024; 14(1):143-158.

PMID: 38164139 PMC: 10750202. DOI: 10.7150/thno.89066.

References

Percival C, Richtsmeier J . Angiogenesis and intramembranous osteogenesis. Dev Dyn. 2013; 242(8):909-22. PMC: 3803110. DOI: 10.1002/dvdy.23992. View

Martinez-Greene J, Hernandez-Ortega K, Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair D . Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography. J Extracell Vesicles. 2021; 10(6):e12087. PMC: 8077108. DOI: 10.1002/jev2.12087. View

Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J . Engineered Human Adipose Stem-Cell-Derived Exosomes Loaded with miR-21-5p to Promote Diabetic Cutaneous Wound Healing. Mol Pharm. 2020; 17(5):1723-1733. DOI: 10.1021/acs.molpharmaceut.0c00177. View

Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z . Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2019; 103:196-212. DOI: 10.1016/j.actbio.2019.12.020. View

Clarke B . Normal bone anatomy and physiology. Clin J Am Soc Nephrol. 2008; 3 Suppl 3:S131-9. PMC: 3152283. DOI: 10.2215/CJN.04151206. View

Borciani G, Montalbano G, Baldini N, Cerqueni G, Vitale-Brovarone C, Ciapetti G . Co-culture systems of osteoblasts and osteoclasts: Simulating in vitro bone remodeling in regenerative approaches. Acta Biomater. 2020; 108:22-45. DOI: 10.1016/j.actbio.2020.03.043. View

Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

Behera J, Kumar A, Voor M, Tyagi N . Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1/Tie2-NO signaling in CBS-heterozygous mice. Theranostics. 2021; 11(16):7715-7734. PMC: 8315071. DOI: 10.7150/thno.58410. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

10.

Hu H, Wang D, Li L, Yin H, He G, Zhang Y . Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021; 12(2):156. PMC: 7862274. DOI: 10.1038/s41419-021-03430-3. View

11.

Li B, Xu H, Han H, Song S, Zhang X, Ouyang L . Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018; 37(41):5508-5519. DOI: 10.1038/s41388-018-0359-0. View

12.

Alzhrani G, Alanazi S, Alsharif S, Albalawi A, Alsharif A, Abdel-Maksoud M . Exosomes: Isolation, characterization, and biomedical applications. Cell Biol Int. 2021; 45(9):1807-1831. DOI: 10.1002/cbin.11620. View

13.

Nan K, Zhang Y, Zhang X, Li D, Zhao Y, Jing Z . Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu). Stem Cell Res Ther. 2021; 12(1):331. PMC: 8186190. DOI: 10.1186/s13287-021-02390-x. View

14.

Wang X, Thomsen P . Mesenchymal stem cell-derived small extracellular vesicles and bone regeneration. Basic Clin Pharmacol Toxicol. 2020; 128(1):18-36. PMC: 7820981. DOI: 10.1111/bcpt.13478. View

15.

Jia B, Wang Z, Sun X, Chen J, Zhao J, Qiu X . Long noncoding RNA LINC00707 sponges miR-370-3p to promote osteogenesis of human bone marrow-derived mesenchymal stem cells through upregulating WNT2B. Stem Cell Res Ther. 2019; 10(1):67. PMC: 6387535. DOI: 10.1186/s13287-019-1161-9. View

16.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

17.

Liu A, Lin D, Zhao H, Chen L, Cai B, Lin K . Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway. Biomaterials. 2021; 272:120718. DOI: 10.1016/j.biomaterials.2021.120718. View

18.

Wu M, Liu X, Li Z, Huang X, Guo H, Guo X . SHED aggregate exosomes shuttled miR-26a promote angiogenesis in pulp regeneration via TGF-β/SMAD2/3 signalling. Cell Prolif. 2021; 54(7):e13074. PMC: 8249784. DOI: 10.1111/cpr.13074. View

19.

McBride J, Rodriguez-Menocal L, Badiavas E . Extracellular Vesicles as Biomarkers and Therapeutics in Dermatology: A Focus on Exosomes. J Invest Dermatol. 2017; 137(8):1622-1629. DOI: 10.1016/j.jid.2017.04.021. View

20.

Cooper D, Wang C, Patel R, Trujillo A, Patel N, Prather J . Human Adipose-Derived Stem Cell Conditioned Media and Exosomes Containing Promote Human Dermal Fibroblast Migration and Ischemic Wound Healing. Adv Wound Care (New Rochelle). 2018; 7(9):299-308. PMC: 6158770. DOI: 10.1089/wound.2017.0775. View